Outcomes

ClinChoice Acquires CROMSOURCE to Expand CRO Capabilities Globally

ClinChoice has acquired CROMSOURCE to expand their CRO capabilities globally.

Outcomes

anteris Acquired by Kymanox, a Portfolio Company of Westview Capital Partners, to Expand Injectable Combination Product Development Capabilities Globally

Transaction helps both companies realize their shared goals of geographic expansion, while also bolstering service capabilities.

Outcomes

OpenClinica Completes Growth Recapitalization with Thompson Street Capital Partners to Accelerate Enablement of Clinical Trials

The company’s service offerings were the ideal strategic complement to enhance Syner-G’s existing suite of comprehensive CMC solutions.

Outcomes

Clairvest Acquires Boca Biolistics to Accelerate Growth of Infectious Disease and Oncological Biobanking Capabilities

Boca’s high growth profile and differentiated positioning within the biobanking industry made it the ideal acquisition for Clairvest’s ongoing multi-year domain effort in the life sciences industry.

Outcomes

RMC Pharmaceutical Solutions Acquired by Syner-G Biopharma Group, a Portfolio Company of Riverside Partners, to Expand Regulatory Compliance Solutions

The company’s service offerings were the ideal strategic complement to enhance Syner-G’s existing suite of comprehensive CMC solutions.

Outcomes

LongueVue Capital Partners Acquires Majority Stake in Summit Clinical Research to Accelerate SMO/IRO Growth

LongueVue Capital Partners has acquired a majority stake in Summit Clinical Research to accelerate SMO/IRO growth.

Outcomes

Sabai Global Acquired by Thompson Street Capital Partners to Accelerate IBC and IRB Growth

Sabai's specialized services made the Company the ideal target for a strategic growth investment from Thompson Street Capital Partners.

Outcomes

H.I.G. Capital Acquires Majority Stake in Navitas Life Sciences to Accelerate CRO Growth

Lexitas Pharma Services has been acquired by NovaQuest Private Equity to support continued growth and capability expansion.

Outcomes

Lexitas Acquired by NovaQuest to Support Continued Growth and Capability Expansion

Lexitas Pharma Services has been acquired by NovaQuest Private Equity to support continued growth and capability expansion.

Outcomes

CCRC Recapitalized by Martis Capital Via Its Newly Formed Clinical Research Site Platform, Alcanza Clinical Research

Coastal Carolina Research Center has been recapitalized by Martis Capital via its newly formed clinical research site platform, Alcanza Clinical Research.